Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast

American Journal of Pathology

Volumn 169, Issue 3, 2006, Pages 774-783

  Bainbridge, Shannon A ^a   Belkacemi, Louiza ^a   Dickinson, Michelle ^a   Graham, Charles H ^a   Smith, Graeme N ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

APOPTOSIS; ARTICLE; CELL AGING; CELL DAMAGE; CELL PROTECTION; CELL REGENERATION; CONTROLLED STUDY; DRUG EFFECT; EXPLANT; FEMALE; HUMAN; HUMAN TISSUE; HYPOXIA; IN VITRO STUDY; NECROSIS; NICK END LABELING; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; REOXYGENATION; RISK REDUCTION; SMOKING; SYNCYTIOTROPHOBLAST;

EID: 33748782553     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.060184     Document Type: Article

References (50)

1. Roberts JM, Lain KY: Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002, 23:359-372
2. Walker JJ: Pre-eclampsia. Lancet 2000, 356:1260-1265
3. Redman CW, Sargent IL: Placental debris, oxidative stress and pre-eclampsia. Placenta 2000, 21:597-602
4. Brosens IA, Robertson WB, Dixon HG: The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972, 1:177-191
5. Lim KH, Zhou Y, Janatpour M, McMaster M, Bass K, Chun SH, Fisher SJ: Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol 1997, 151:1809-1818
6. Hung TH, Skepper JN, Burton GJ: In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 2001, 159:1031-1043
7. Meekins J, Pijnenborg R, Hanssens M, McFadyen I, van Asshe A: A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994, 101:669-674
8. Collard CD, Gelman S: Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology 2001, 94:1133-1138
9. Vaage J, Valen G: Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery. A review. Scand J Thorac Cardiovasc Surg Suppl 1993, 41:1-18
10. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ: Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 2004, 164:1049-1061
11. Hung TH, Skepper JN, Charnock-Jones DS, Burton GJ: Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 2002, 90:1274-1281
12. Sacks GP, Seyani L, Lavery S, Trew G: Maternal C-reactive protein levels are raised at 4 weeks gestation. Hum Reprod 2004, 19:1025-1030
13. Morris JM, Gopaul NK, Endresen MJ, Knight M, Linton EA, Dhir S, Anggard EE, Redman CW: Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 1998, 11:1195-1199
14. Knight M, Redman CW, Linton EA, Sargent IL: Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol 1998, 105:632-640
15. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA: Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Miorocirculation 2002, 9:147-160
16. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA: Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 2001, 38:718-722
17. Duckitt K, Harrington D: Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005, 330:565
18. Eskenazi B, Fenster L, Sidney S: A multivariate analysis of risk factors for preeclampsia. JAMA 1991, 266:237-241
19. Smith G, Walker M, Tessier J, Millar K: Increased incidence of pre-eclampsia in women conceiving by intrauterine insemination with donor versus partner sperm for treatment of primary infertility. Am J Obstet Gynecol 1997, 177:455-458
20. Bainbridge SA, Sidle EH, Smith GN: Direct placental effects of cigarette smoke protect women from pre-eclampsia: the specific roles of carbon monoxide and antioxidant systems in the placenta. Med Hypotheses 2005, 64:17-27
21. England L, Levine R, Mills J, Klebanoff M, Yu K, Cnattingius S: Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol 2003, 189:939-943
22. Christova T, Diankova Z, Setchenska M: Heme oxygenase-carbon monoxide signalling pathway as a physiological regulator of vascular smooth muscle cells. Acta Physiol Pharmacol Bulg 2000, 25:9-17
23. Vreman HJ, Mahoney JJ, Stevenson DK: Carbon monoxide and carboxyhemoglobin. Adv Pediatr 1995, 42:303-325
24. Ryter SW, Otterbein LE: Carbon monoxide in biology and medicine. Bioessays 2004, 26:270-280
25. Bainbridge SA, Smith GN: HO in pregnancy. Free Radic Biol Med 2005, 38:979-988
26. Lyall F, Barber A, Myatt L, Bulmer JN, Robson SC: Hemeoxygenase expression in human placenta and placental bed implies a role in regulation of trophoblast invasion and placental function. FASEB J 2000, 14:208-219
27. Bainbridge SA, Farley AE, McLaughlin BE, Graham CH, Marks GS, Nakatsu K, Smith GN: Carbon monoxide decreases perfusion pressure in isolated human placenta. Placenta 2002, 23:563-569
28. Baum M, Schiff E, Kreiser D, Dennery PA, Stevenson DK, Rosenthal T, Seidman DS: End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol 2000, 183:900-903
29. Kreiser D, Baum M, Seidman DS, Fanaroff A, Shah D, Hendler I, Stevenson DK, Schiff E, Druzin ML: End tidal carbon monoxide levels are lower in women with gestational hypertension and pre-eclampsia. J Perinatal 2004, 24:213-217
30. Katori M, Busuttil R, Kupiec-Weglinski J: Heme oxygenase-1 system in organ transplantation. Transplantation 2002, 74:905-912
31. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, Choi AM, Bach FH, Soares MP: Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 2001, 166:4185-4194
32. Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, Sato K, Grey ST, Colvin RB, Choi AM, Poss KD, Bach FH: Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998, 4:1073-1077
33. Ke B, Buelow R, Shen X, Melinek J, Amersi F, Gao F, Ritter T, Volk HD, Busuttil RW, Kupiec-Weglinski JW: Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum Gene Ther 2002, 13:1189-1199
34. Chauveau C, Bouchet D, Roussel JC, Mathieu P, Braudeau C, Renaudin K, Tesson L, Soulillou JP, Iyer S, Buelow R, Anegon I: Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2002, 2:581-592
35. Neto JS, Nakao A, Kimizuka K, Romanosky AJ, Stolz DB, Uchiyama T, Nalesnik MA, Otterbein LE, Murase N: Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol 2004, 287:F979-F989
36. Song R, Kubo M, Morse D, Zhou Z, Zhang X, Dauber JH, Fabisiak J, Alber SM, Watkins SC, Zuckerbraun BS, Otterbein LE, Ning W, Oury TD, Lee PJ, McCurry KR, Choi AM: Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol 2003, 163:231-242
37. Akamatsu Y, Haga M, Tyagi S, Yamashita K, Graca-Souza AV, Ollinger R, Czismadia E, May GA, Ifedigbo E, Otterbein LE, Bach FH, Soares MP: Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury. FASEB J 2004, 18:771-772
38. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, Soares MP: Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000, 192:1015-1026
39. Liu XM, Chapman GB, Peyton KJ, Schafer AI, Durante W: Antiapoptotic action of carbon monoxide on cultured vascular smooth muscle cells. Exp Biol Med 2003, 228:572-575
40. Siman CM, Sibley CP, Jones CJ, Turner MA, Greenwood SL: The functional regeneration of syncytiotrophoblast in cultured explants of term placenta. Am J Physiol 2001, 280:R1116-R1122
41. Fujikura T, Yoshida J: Blood gas analysis of placental and uterine blood during cesarean delivery. Obstet Gynecol 1996, 87:133-136
42. Soothill PW, Nicolaides KH, Rodeck CH, Campbell S: Effect of gestational age on fetal and intervillous blood gas and acid-base values in human pregnancy. Fetal Ther 1986, 1:168-175
43. Watson AL, Skepper JN, Jauniaux E, Burton GJ: Susceptibility of human placental syncytiotrophoblastic mitochondria to oxygen-mediated damage in relation to gestational age. J Clin Endocrinol Metab 1998, 83:1697-1705
44. Bainbridge SA, Bourne L, McLaughlin BE, Graham CH, Brien JF, Nakatsu K, Smith GN: Carbon monoxide concentrations in umbilical cord and maternal blood from smokers vs. non-smokers. Placenta 2003, 24:A14
45. Leung DN, Smith SC, To KF, Sahota DS, Baker PN: Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001, 184:1249-1250
46. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA: Placental apoptosis in preeclampsia. Obstet Gynecol 2000, 96:271-276
47. Formigli L, Papucci L, Tani A, Schiavone N, Tempestini A, Orlandini GE, Capaccioli S, Orlandini SZ: Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol 2000, 182:41-49
48. Chua S, Wilkins T, Sargent I, Redman C: Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol 1991, 98:973-979
49. Baranano DE, Rao M, Ferris CD, Snyder SH: Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 2002, 99:16093-16098
50. Liu XM, Chapman GB, Peyton KJ, Schafer AI, Durante W: Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res 2002, 55:396-405